These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 30139638)
1. Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study. Donnenfeld ED; Solomon KD; Matossian C J Cataract Refract Surg; 2018 Oct; 44(10):1236-1246. PubMed ID: 30139638 [TBL] [Abstract][Full Text] [Related]
2. Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated with Cataract Surgery: A Randomized, Placebo-Controlled, Phase III Trial. Donnenfeld E; Holland E Ophthalmology; 2018 Jun; 125(6):799-806. PubMed ID: 29397189 [TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye. Tan DT; Chee SP; Lim L; Theng J; Van Ede M Ophthalmology; 2001 Dec; 108(12):2172-81. PubMed ID: 11733254 [TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Tan DT; Chee SP; Lim L; Lim AS Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469 [TBL] [Abstract][Full Text] [Related]
5. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Karalezli A; Borazan M; Akova YA Acta Ophthalmol; 2008 Mar; 86(2):183-7. PubMed ID: 18162061 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification. Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636 [TBL] [Abstract][Full Text] [Related]
7. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA; Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378 [TBL] [Abstract][Full Text] [Related]
8. Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. Kavuncu S; Horoz H; Ardagil A; Erbil HH Int Ophthalmol; 2008 Aug; 28(4):281-5. PubMed ID: 17762913 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery. Yaylali V; Ozbay D; Tatlipinar S; Yildirim C; Ozden S Int Ophthalmol; 2004 Jan; 25(1):65-8. PubMed ID: 15085979 [TBL] [Abstract][Full Text] [Related]
11. Phase II results of an intraocular steroid delivery system for cataract surgery. Chang DF; Garcia IH; Hunkeler JD; Minas T Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088 [TBL] [Abstract][Full Text] [Related]
12. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery. Walters T; Endl M; Elmer TR; Levenson J; Majmudar P; Masket S J Cataract Refract Surg; 2015 Oct; 41(10):2049-59. PubMed ID: 26703279 [TBL] [Abstract][Full Text] [Related]
13. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. Dieleman M; Wubbels RJ; van Kooten-Noordzij M; de Waard PW J Cataract Refract Surg; 2011 Sep; 37(9):1589-97. PubMed ID: 21855759 [TBL] [Abstract][Full Text] [Related]
14. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Wilson ME; O'Halloran H; VanderVeen D; Roarty J; Plager DA; Markwardt K; Gedif K; Lambert SR Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. Lane SS; Osher RH; Masket S; Belani S J Cataract Refract Surg; 2008 Sep; 34(9):1451-9. PubMed ID: 18721703 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components. Cunha PA; Shinzato FA; Tecchio GT; Weber SL; Brasil A; Avakian A Clinics (Sao Paulo); 2013 Jun; 68(6):834-9. PubMed ID: 23778476 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle. Lorenz K; Dick B; Jehkul A; Auffahrt GU Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1617-22. PubMed ID: 18726610 [TBL] [Abstract][Full Text] [Related]